Mandate

Vinge advises Bilia on refinancing

March 27, 2024 Banking and Finance

Vinge had advised Bilia AB (publ) in connection with the SEK 2.3 billion refinancing of its existing revolving loan and credit facilities.

The new credit facility amounts to SEK 2,300 million, with a split of SEK 1,700 million in revolving loans and SEK 600 million in overdraft loans. The revolving loans have a tenor three years with an extension option (one plus one years) upon the lenders approval. DNB and Nordea are the original lenders under the new credit facility.

Together with outstanding unsecured bonds of SEK 1,300 million, in relation to which Vinge has also advised Bilia, the credit facility constitutes a significant part of Bilia’s long-term core financing.

Vinge’s team consisted of Anders Strid, Lionardo Ojeda, Sofia Haggren and Frithiof Hallgren Wallin.

Related

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025